Islet cell tumor arising from a heterotopic pancreas in the duodenal wall with ulceration

Experimental and Molecular Pathology

Volumn 76, Issue 1, 2004, Pages 51-56

  Tolentino, Lucilene F ^a   Lee, Hanson ^a   Maung, Tony ^a   Stabile, Bruce E ^a   Li, Kewang ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Carcinoid; Duodenum; Ectopic; Heterotopic; Islet amyloid polypeptide; Islet cell tumor; Nonfunctioning; Pancreas; Periampullary; Submucosal

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE COURSE; DUODENUM MUCOSA; ECTOPIC PANCREAS; ENDOCRINE TUMOR; FIBERSCOPE ENDOSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL EXAMINATION; PANCREAS ADENOMA; PANCREAS BIOPSY; PEPTIC ULCER BLEEDING; POSTOPERATIVE PERIOD; RECTOSCOPY; TISSUE SECTION;

EID: 0347301681     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.08.005     Document Type: Article

References (31)

1. Barbosa J.J., Dockerty M.B., Waugh J.M. Pancreatic heterotopia: a review of the literature and report of 41 authenticated cases, of which 25 were clinically significant. Surg. Gynecol. Obstet. 82:1946;527-542.
2. Broder L.E., Carter S.K. Pancreatic islet cell carcinoma: II. Results of treatment with streptozotocin in 52 patients. Ann. Intern. Med. 79:1973;108-118.
3. Broughan T.A., Leslie J.D., Soto J.M., Hermann R.E. Pancreatic islet cell tumors. Surgery. 99:1986;671-678.
4. Dial P.F., Braasch J.W., Rossi R.L., Lee A.K., Jin G. Management of nonfunctioning islet cell tumors of the pancreas. Surg. Clin. North Am. 65:1985;291-299.
5. Dolan R.V., ReMine W.H., Dockerty M.B. The fate of heterotopic pancreatic tissue. A study of 212 cases. Arch. Surg. 109:1974;762-765.
6. Donow C., Pipeleer-Marichal M., Stamm B.et al. Pathologie des Insulinoms und Gastrinoms. Lokalisation, Grobe, Multizentrizitat, Assoziation mit der multiplen Endokrinen Neoplasie Typ I und Malignitat. Dtsch. Med. Wochenschr. 115:1990;1386-1391.
7. Goldfarb W.B., Bennett D., Monafo W. Carcinoma in heterotopic gastric pancreas. Ann. Surg. 158:1963;56-59.
8. Grimelius L., Hulquist G.T., Stenkvist B. Cytologic differentiation of asymptomatic pancreatic islet cell tumors on autopsy material. Virchows Arch. A. 365:1975;275-288.
9. Heinrich H. Ein Beitrag zur Histologie des sogen. Akzessorischen Pankreas. Virchows Arch. 198:1909;392-401.
10. Heitz P.U., Kasper M., Polak J.M.et al. Pancreatic endocrine tumours. Immunohistochemical analysis of 125 tumours. Human Pathol. 13:1982;263-271.
11. Hickman D.M., Frey C.F., Carson J.W. Adenocarcinoma arising in gastric heterotopic pancreas. West. J. Med. 135:1981;57-62.
12. Jaffe R. The pancreas. Wigglesworth J.S., Singer D.B. Textbook of Fetal and Perinatal Pathology. vol. 2:1991;1021-1055 Blackwell, Boston.
13. Kent R.B., van Heerden J.A., Weiland L.H. Nonfunctioning islet cell tumors. Ann. Surg. 193:1981;185-190.
14. Kimura W., Kuroda A., Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig. Dis. Sci. 36:1991;933-942.
15. Kloppel G., Heitz P.U. Pancreatic endocrine tumors. Pathol. Res. Pract. 183:1988;155-168.
16. Matsumoto Y., Kawai Y., Kimura K. Aberrant pancreas causing pyloric obstruction. Surgery. 76:1974;827-829.
17. Moertel G.C., Hanley J.A., Johnson L.A. Streptozotocin alone compared with Streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N. Engl. J. Med. 303:1980;1189-1194.
18. Mukai K., Grotting J.C., Greider M.H., Rosai J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am. J. Surg. Pathol. 6:1982;387-399.
19. Nopajaroonsri C. Mucus retention in heterotopic pancreas of the gastric antrum. Am. J. Surg. Pathol. 18:1994;953-957.
20. Padberg B.C., Schroder S. Letter. Am. J. Surg. Pathol. 19:1995;1445-1446.
21. Rindi G., Terenghi G., Westermark G.et al. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice. Am. J. Pathol. 138:1991;1321-1334.
22. Rosai J. Pancreas and periampullary region. Rosai J. Ackerman's Surgical Pathology. Seventh ed., vol. 1:1989;757 Mosby, St. Louis.
23. Seifert G. Congenital anomalies. Kloppel G., Heitz P.H. Pancreatic Pathology. 1984;27-31 Churchill, Edinburgh.
24. Solcia E., Sessa F., Rindi G., Bonato M., Capella C. Pancreatic endocrine tumors: general concepts; nonfunctioning tumors and tumors with uncommon functions. Dayal Y. Endocrine Pathology of the Gut and Pancreas. 1991;105-131 CRC Press, Boca Raton.
25. Solcia E., Capella C., Kloppel G. Tumors of the endocrine pancreas. Atlas of Tumor pathology, tumors of the pancreas. Fasc. 20:1997;145-209.
26. Stake K., Uchman K., Yamashita K., Yoshimoto T., Umeyama K. Pancreatic cystadenoma of the spleen. Am. J. Surg. 137:1979;670-672.
27. Stridsberg M., Berne C., Sandler S.et al. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of islet amyloid polypeptide-like molecule. Diabetologia. 36:1993;843-849.
28. Tanimura A., Yamamoto H., Shibata H., Sano E. Carcinoma in heterotopic gastric pancreas. Acta Pathol. Jpn. 29:1979;251-257.
29. Tomita T., Kanabe S. Islet tissue in heterotopic pancreas. Arch. Pathol. Lab. Med. 107:1983;469-472.
30. Westermark G., Grimelius L., Polak J.M.et al. Amyloid in polypeptide hormone-producing tumors. Lab. Invest. 37:1977;212-215.
31. Westermark P., Engstrom U., Johnson K.H.et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5036-5040.